Okay, let's summarize what has transpired here. Bob Schneiderman has sent out several PRs during the past months announcing plans to market RapiMeds in Hong Kong. Several questioned his ability to actually make this become reality. Today he sent out the PR stating final approval to launch RapiMeds in Hong Kong has been received. Now I ask you, here is a man who has dedicated several months to make this vision a reality. Why is there concern about financing manufacturing? Wouldn't one think that he is on top of that as well? With this fantastic news today, I have gained a higher level of respect for Mr. Schneiderman and confirm that I have no concerns for the manner in which he is conducting SCRC business. I have trusted Mr. Schneiderman and continue to do so. He has followed through with all his promises to make SCRC a successful company. Those of us who have maintained our patience will soon begin to enjoy the rewards. [b]A REAL COMPANY, with a REAL PRODUCT, and a REAL LEADER.[/b] Keep in mind, Hong Kong is just one of several revenue streams Mr. Schneiderman has developed. SCRC's potential in the months to follow is ENDLESS!